209 related articles for article (PubMed ID: 23246440)
1. Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
Huerta-Yepez S; Baritaki S; Baay-Guzman G; Hernandez-Luna MA; Hernandez-Cueto A; Vega MI; Bonavida B
Nitric Oxide; 2013 Feb; 29():17-24. PubMed ID: 23246440
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.
Huerta-Yepez S; Vega M; Escoto-Chavez SE; Murdock B; Sakai T; Baritaki S; Bonavida B
Nitric Oxide; 2009 Feb; 20(1):39-52. PubMed ID: 18778787
[TBL] [Abstract][Full Text] [Related]
3. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.
Bonavida B; Baritaki S
Nitric Oxide; 2011 Jan; 24(1):1-7. PubMed ID: 20933602
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate: Involvement of AIF.
Huerta S; Baay-Guzman G; Gonzalez-Bonilla CR; Livingston EH; Huerta-Yepez S; Bonavida B
Nitric Oxide; 2009 May; 20(3):182-94. PubMed ID: 19105980
[TBL] [Abstract][Full Text] [Related]
5. Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.
Martinez-Paniagua MA; Vega MI; Huerta-Yepez S; Baritaki S; Vega GG; Hariharan K; Bonavida B
Mol Cancer Ther; 2012 Mar; 11(3):572-81. PubMed ID: 22267549
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation.
Hongo F; Garban H; Huerta-Yepez S; Vega M; Jazirehi AR; Mizutani Y; Miki T; Bonavida B
Biochem Biophys Res Commun; 2005 Oct; 336(2):692-701. PubMed ID: 16143308
[TBL] [Abstract][Full Text] [Related]
9. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics.
Bonavida B; Garban H
Redox Biol; 2015 Dec; 6():486-494. PubMed ID: 26432660
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
Baritaki S; Huerta-Yepez S; Sakai T; Spandidos DA; Bonavida B
Mol Cancer Ther; 2007 Apr; 6(4):1387-99. PubMed ID: 17431117
[TBL] [Abstract][Full Text] [Related]
12. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
Baritaki S; Katsman A; Chatterjee D; Yeung KC; Spandidos DA; Bonavida B
J Immunol; 2007 Oct; 179(8):5441-53. PubMed ID: 17911631
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.
Bonavida B; Baritaki S; Huerta-Yepez S; Vega MI; Chatterjee D; Yeung K
Nitric Oxide; 2008 Sep; 19(2):152-7. PubMed ID: 18477483
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization of HT-29 cells and xenografts by the nitric oxide donor DETANONOate.
Gao X; Saha D; Kapur P; Anthony T; Livingston EH; Huerta S
J Surg Oncol; 2009 Aug; 100(2):149-58. PubMed ID: 19507186
[TBL] [Abstract][Full Text] [Related]
15. A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.
Vega MI; Baritaki S; Huerta-Yepez S; Martinez-Paniagua MA; Bonavida B
Leuk Lymphoma; 2011 Jan; 52(1):108-21. PubMed ID: 21133714
[TBL] [Abstract][Full Text] [Related]
16. Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy.
Rapozzi V; Della Pietra E; Bonavida B
Redox Biol; 2015 Dec; 6():311-317. PubMed ID: 26319434
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic YY1 Inhibitors in Cancer: ALL in ONE.
Bonavida B
Crit Rev Oncog; 2017; 22(1-2):37-47. PubMed ID: 29604935
[TBL] [Abstract][Full Text] [Related]
18. Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
Rieger C; Huebner D; Temme A; Wirth MP; Fuessel S
Int J Oncol; 2015 Sep; 47(3):1121-30. PubMed ID: 26201840
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP.
Baritaki S; Huerta-Yepez S; Sahakyan A; Karagiannides I; Bakirtzi K; Jazirehi A; Bonavida B
Cell Cycle; 2010 Dec; 9(24):4931-40. PubMed ID: 21150329
[TBL] [Abstract][Full Text] [Related]
20. A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study.
Rapozzi V; Varchi G; Della Pietra E; Ferroni C; Xodo LE
Invest New Drugs; 2017 Feb; 35(1):115-123. PubMed ID: 27726093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
